2B7D
| Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model | 分子名称: | (2R)-2-[5-(5-CARBAMIMIDOYL-1H-BENZOIMIDAZOL-2-YL)-6,2'-DIHYDROXY-5'-UREIDOMETHYL-BIPHENYL-3-YL]-SUCCINIC ACID, Coagulation factor VII, Tissue factor | 著者 | Young, W.B, Mordenti, J, Torkelson, S, Shrader, W.D, Kolesnikov, A, Rai, R, Liu, L, Hu, H, Leahy, E.M, Green, M.J, Sprengeler, P.A, Katz, B.A, Yu, C, Janc, J.W, Elrod, K.C, Marzec, U.M, Hanson, S.R. | 登録日 | 2005-10-04 | 公開日 | 2006-02-14 | 最終更新日 | 2023-08-23 | 実験手法 | X-RAY DIFFRACTION (2.24 Å) | 主引用文献 | Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model. Bioorg.Med.Chem.Lett., 16, 2006
|
|
2FLR
| Novel 5-Azaindole Factor VIIa Inhibitors | 分子名称: | Coagulation factor VII, Tissue factor, [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA | 著者 | Riggs, J.R, Hu, H, Kolesnikov, A, Tong, Z, Leahy, E.M, Wesson, K.E, Shrader, W.D, Vijaykumar, D, Wahl, T.A, Sprengeler, P.A, Green, M.J, Yu, C, Katz, B.A, Young, W.B. | 登録日 | 2006-01-06 | 公開日 | 2007-01-23 | 最終更新日 | 2017-10-18 | 実験手法 | X-RAY DIFFRACTION (2.35 Å) | 主引用文献 | Novel 5-azaindole factor VIIa inhibitors. Bioorg.Med.Chem.Lett., 16, 2006
|
|
2FS9
| Human beta tryptase II with inhibitor CRA-28427 | 分子名称: | ETHYL {(1S)-5-AMINO-1-[(5-{4-[(2,3-DIHYDRO-1H-INDEN-2-YLAMINO)CARBONYL]BENZYL}-1,2,4-OXADIAZOL-3-YL)CARBONYL]PENTYL}CARBAMATE, Tryptase beta-2 | 著者 | Somoza, J.R. | 登録日 | 2006-01-21 | 公開日 | 2006-03-07 | 最終更新日 | 2017-10-18 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Structure-guided design of Peptide-based tryptase inhibitors. Biochemistry, 45, 2006
|
|
2FXR
| |
3PHE
| HCV NS5B with a bound quinolone inhibitor | 分子名称: | 4-chlorobenzyl 6-fluoro-7-(4-methylpiperazin-1-yl)-1-[4-(methylsulfonyl)benzyl]-4-oxo-1,4-dihydroquinoline-3-carboxylate, HCV encoded nonstructural 5B protein | 著者 | Somoza, J.R, To, N, Lehoux, I. | 登録日 | 2010-11-03 | 公開日 | 2010-11-17 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Quinolones as HCV NS5B polymerase inhibitors. Bioorg.Med.Chem.Lett., 21, 2011
|
|
3UDL
| 3-heterocyclyl quinolone bound to HCV NS5B | 分子名称: | 3-(5-benzyl-1,2,4-oxadiazol-3-yl)-6-fluoro-1-[2-fluoro-4-(trifluoromethyl)benzyl]-7-(4-methylpiperazin-1-yl)quinolin-4(1H)-one, HCV NS5B polymerase | 著者 | Somoza, J.R. | 登録日 | 2011-10-28 | 公開日 | 2011-12-21 | 実験手法 | X-RAY DIFFRACTION (2.174 Å) | 主引用文献 | Quinolones as HCV NS5B polymerase inhibitors. Bioorg.Med.Chem.Lett., 21, 2011
|
|
2FX4
| |
2FX6
| |
2FWW
| |
2FPZ
| |
2FS8
| Human beta-tryptase II with inhibitor CRA-29382 | 分子名称: | ALLYL {(1S)-1-[(5-{4-[(2,3-DIHYDRO-1H-INDEN-2-YLAMINO)CARBONYL]BENZYL}-1,2,4-OXADIAZOL-3-YL)CARBONYL]-3-PYRROLIDIN-3-YLPROPYL}CARBAMATE, Tryptase beta-2 | 著者 | Somoza, J.R. | 登録日 | 2006-01-21 | 公開日 | 2006-03-21 | 最終更新日 | 2017-10-18 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | Structure-guided design of Peptide-based tryptase inhibitors. Biochemistry, 45, 2006
|
|
5V7X
| Crystal Structure of Myosin 1b residues 1-728 with bound sulfate and Calmodulin | 分子名称: | Calmodulin-1, SULFATE ION, Unconventional myosin-Ib | 著者 | Zwolak, A, Shuman, H, Dominguez, R, Ostap, E.M. | 登録日 | 2017-03-20 | 公開日 | 2018-02-28 | 最終更新日 | 2024-03-06 | 実験手法 | X-RAY DIFFRACTION (3.141 Å) | 主引用文献 | High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. Proc. Natl. Acad. Sci. U.S.A., 115, 2018
|
|
4L79
| Crystal Structure of nucleotide-free Myosin 1b residues 1-728 with bound Calmodulin | 分子名称: | Calmodulin, MAGNESIUM ION, Unconventional myosin-Ib | 著者 | Shuman, H, Zwolak, A, Dominguez, R, Ostap, E.M. | 登録日 | 2013-06-13 | 公開日 | 2014-01-29 | 最終更新日 | 2023-09-20 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | A vertebrate myosin-I structure reveals unique insights into myosin mechanochemical tuning. Proc.Natl.Acad.Sci.USA, 111, 2014
|
|